Analysis | Metabolite Name | Measured Value | Units | Treatment | Time Point |
---|---|---|---|---|---|
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 1882.4 | Peak area | Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 2267.0 | Peak area | Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 2283.6 | Peak area | Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 2699.1 | Peak area | Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 2857.8 | Peak area | Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 4438.0 | Peak area | Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 5647.3 | Peak area | Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 7024.3 | Peak area | Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 7890.6 | Peak area | Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 8010.9 | Peak area | Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 8313.3 | Peak area | Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 9928.2 | Peak area | Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 10860.4 | Peak area | Human Adipocytes grown in the ABSENCE of SKOV3ip1 OvCa Cells (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 13826.0 | Peak area | Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 19438.9 | Peak area | Human Adipocytes grown in the PRESENCE of SKOV3ip1 OvCa cells (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 442750.4 | Peak area | SKOV3ip1 OvCa cells grown in the PRESENCE of Human Adipocytes (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 452536.0 | Peak area | SKOV3ip1 OvCa cells grown in the PRESENCE of Human Adipocytes (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 484452.8 | Peak area | SKOV3ip1 OvCa cells grown in the ABSENCE of human adipocytes (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 485359.2 | Peak area | SKOV3ip1 OvCa cells grown in the ABSENCE of human adipocytes (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 536371.8 | Peak area | SKOV3ip1 OvCa cells grown in the PRESENCE of Human Adipocytes (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 552491.1 | Peak area | SKOV3ip1 OvCa cells grown in the ABSENCE of human adipocytes (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 558220.3 | Peak area | SKOV3ip1 OvCa cells grown in the PRESENCE of Human Adipocytes (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 561159.8 | Peak area | SKOV3ip1 OvCa cells grown in the PRESENCE of Human Adipocytes (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 587553.8 | Peak area | SKOV3ip1 OvCa cells grown in the ABSENCE of human adipocytes (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 600328.7 | Peak area | SKOV3ip1 OvCa cells grown in the ABSENCE of human adipocytes (Control) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 637047.0 | Peak area | SKOV3ip1 OvCa cells grown in the PRESENCE of Human Adipocytes (Co-Culture) | 4 hours |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | Peak area | Media from Human Adipocytes and SKOV3ip1 OvCa Cells Co-Cultured | 4 hours | |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | Peak area | Media from Human Adipocytes Culturing Only | 4 hours | |
UHPLC-QTOFMS positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | Peak area | Media from SKOV3ip1 OvCa Cells Culturing Only | 4 hours |